Koninklijke DSM (OTCMKTS:RDSMY) Rating Increased to Buy at Zacks Investment Research


Share on StockTwits

Koninklijke DSM (OTCMKTS:RDSMY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Tuesday, Zacks.com reports. The firm currently has a $49.00 target price on the basic materials company’s stock. Zacks Investment Research‘s target price suggests a potential upside of 11.19% from the stock’s current price.

According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “

A number of other brokerages have also issued reports on RDSMY. Morgan Stanley reissued an “equal weight” rating on shares of Koninklijke DSM in a report on Wednesday, October 14th. Credit Suisse Group restated a “neutral” rating on shares of Koninklijke DSM in a research report on Wednesday, November 4th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Koninklijke DSM in a research report on Tuesday, November 10th. Three analysts have rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $49.00.

Shares of RDSMY stock opened at $44.07 on Tuesday. Koninklijke DSM has a 12-month low of $22.86 and a 12-month high of $44.71. The firm has a market capitalization of $31.98 billion, a price-to-earnings ratio of 44.97, a price-to-earnings-growth ratio of 3.12 and a beta of 0.96. The business has a 50 day simple moving average of $42.26 and a 200 day simple moving average of $40.34. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.09 and a quick ratio of 1.30.

Koninklijke DSM (OTCMKTS:RDSMY) last issued its quarterly earnings data on Tuesday, November 3rd. The basic materials company reported $0.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.01). Koninklijke DSM had a return on equity of 10.20% and a net margin of 6.97%. The business had revenue of $2.29 billion during the quarter. On average, equities analysts anticipate that Koninklijke DSM will post 1.32 EPS for the current fiscal year.

Koninklijke DSM Company Profile

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments.

Featured Article: Gap Up Stocks

Get a free copy of the Zacks research report on Koninklijke DSM (RDSMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Koninklijke DSM (OTCMKTS:RDSMY)

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.